High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome

118Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced remission of plasma cell proliferation associated with marked improvement in the patients' performance status, neurologic symptoms, and other manifestations of the syndrome. HDT with stem cell support should be investigated further as a therapeutic option in patients with POEMS syndrome and disseminated plasma cell dyscrasia. © 2002 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Jaccard, A., Royer, B., Bordessoule, D., Brouet, J. C., & Fermand, J. P. (2002). High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood, 99(8), 3057–3059. https://doi.org/10.1182/blood.V99.8.3057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free